US 10828364
Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions
granted A61KA61K2039/55511A61K2039/55516
Quick answer
US patent 10828364 (Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions) held by THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/55511, A61K2039/55516, A61K2039/55522, A61K2039/55555